The Lancet. Infectious diseases
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial..
23:1119-1129.
2023
-
Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990-2019: results from the Global Burden of Disease Study 2019..
22:222-241.
2021
-
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial..
22:97-109.
2021
-
Chlorhexidine for skin antisepsis: making the case to keep peripheral venous catheters CLEAN..
21:902-903.
2021
-
Implications of insecticide resistance for malaria vector control with long-lasting insecticidal nets: a WHO-coordinated, prospective, international, observational cohort study..
18:640-649.
2018
-
Antimicrobial stewardship and public knowledge of antibiotics..
15:1000-1001.
2015
-
Ledipasvir-sofosbuvir for hepatitis C genotype 4 infection..
15:993-995.
2015
Identity
International Standard Serial Number (ISSN)